Torrent Pharmaceuticals Limited Total Assets
Torrent Pharmaceuticals Limited total assets. Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) holds total assets worth Rs443.12 Billion INR (≈ $4.79 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Torrent Pharmaceuticals Limited market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Torrent Pharmaceuticals Limited (2005–2026)
Total assets of Torrent Pharmaceuticals Limited from 2005 to 2026. This chart illustrates how Torrent Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data. See Torrent Pharmaceuticals Limited stock quote for real-time trading data and today's change.
Torrent Pharmaceuticals Limited - Asset Composition Analysis
Torrent Pharmaceuticals Limited Total Assets Breakdown (March 2026)
Torrent Pharmaceuticals Limited total assets breakdown as of March 2026. Torrent Pharmaceuticals Limited's total assets of Rs443.12 Billion consist of 21.2% current assets and 78.8% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 2.6% |
| Accounts Receivable | Rs30.36 Billion | 6.9% |
| Inventory | Rs31.38 Billion | 7.1% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs244.64 Billion | 55.2% |
| Goodwill | Rs39.90 Billion | 9.0% |
Asset Composition Trend (2005–2026)
This chart illustrates how Torrent Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore TORNTPHARM working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Torrent Pharmaceuticals Limited's current assets represent 21.2% of total assets in 2026, a decrease from 37.3% in 2005.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2026, up from 1.5% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 64.0% of total assets, an increase from 13.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 55.2% of total assets.
Torrent Pharmaceuticals Limited Competitors by Total Assets
Key competitors of Torrent Pharmaceuticals Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Torrent Pharmaceuticals Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.13 | 1.19 | 1.13 |
| Quick Ratio | 0.75 | 0.65 | 0.58 |
| Cash Ratio | 0.00 | 0.12 | 0.00 |
| Working Capital | Rs10.49 Billion | Rs9.06 Billion | Rs6.30 Billion |
Torrent Pharmaceuticals Limited - Advanced Valuation Insights
This section examines the relationship between Torrent Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 22.33 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 195.6% |
| Total Assets | Rs443.12 Billion |
| Market Capitalization | $18.98 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Torrent Pharmaceuticals Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Torrent Pharmaceuticals Limited's assets grew by 195.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Torrent Pharmaceuticals Limited (2005–2026)
The table below shows the annual total assets of Torrent Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs443.12 Billion ≈ $4.79 Billion |
+195.61% |
| 2025-03-31 | Rs149.90 Billion ≈ $1.62 Billion |
-0.47% |
| 2024-03-31 | Rs150.61 Billion ≈ $1.63 Billion |
+0.32% |
| 2023-03-31 | Rs150.12 Billion ≈ $1.62 Billion |
+14.60% |
| 2022-03-31 | Rs131.00 Billion ≈ $1.42 Billion |
-6.93% |
| 2021-03-31 | Rs140.75 Billion ≈ $1.52 Billion |
+0.26% |
| 2020-03-31 | Rs140.38 Billion ≈ $1.52 Billion |
-0.59% |
| 2019-03-31 | Rs141.21 Billion ≈ $1.53 Billion |
-0.86% |
| 2018-03-31 | Rs142.43 Billion ≈ $1.54 Billion |
+40.67% |
| 2017-03-31 | Rs101.25 Billion ≈ $1.09 Billion |
+12.33% |
| 2016-03-31 | Rs90.14 Billion ≈ $974.79 Million |
+13.94% |
| 2015-03-31 | Rs79.11 Billion ≈ $855.55 Million |
+56.04% |
| 2014-03-31 | Rs50.70 Billion ≈ $548.28 Million |
+34.02% |
| 2013-03-31 | Rs37.83 Billion ≈ $409.10 Million |
+23.08% |
| 2012-03-31 | Rs30.74 Billion ≈ $332.39 Million |
+20.61% |
| 2011-03-31 | Rs25.48 Billion ≈ $275.60 Million |
+29.68% |
| 2010-03-31 | Rs19.65 Billion ≈ $212.52 Million |
+17.85% |
| 2009-03-31 | Rs16.67 Billion ≈ $180.33 Million |
+31.73% |
| 2008-03-31 | Rs12.66 Billion ≈ $136.90 Million |
+21.14% |
| 2007-03-31 | Rs10.45 Billion ≈ $113.01 Million |
+10.94% |
| 2006-03-31 | Rs9.42 Billion ≈ $101.86 Million |
+32.54% |
| 2005-03-31 | Rs7.11 Billion ≈ $76.85 Million |
-- |
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more